Cite
HARVARD Citation
Nagaoki, Y. et al. (2014). Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C. Hepatology research. 44 (14), pp. E447-E454. [Online].